Its concentration depends on a number of factors, such as the use of corticosteroid therapy, high doses of nonsteroidal anti-inflammatory drugs or treatment with infliximab, which has been reported to increase transthyretin concentrations in patients with IBD [54]. The gene discussed is TTR; the disease is inflammatory bowel disease.